Eton Drug Patent Portfolio
Eton owns 1 orange book drug protected by 3 US patents Given below is the list of Eton's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9649280 | Composition comprising hydrocortisone | 12 May, 2034 | Active |
| US9675559 | Treatment of adrenal insufficiency | 10 Jan, 2033 | Active |
| US9717740 | Treatment of adrenal insufficiency | 19 Nov, 2032 | Active |
Latest Legal Activities on Eton's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Eton.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Yr, Small Entity | 20 Jan, 2021 | US9717740 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 25 Nov, 2020 | US9675559 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 04 Nov, 2020 | US9649280 |
| Mail O.P. Petition Decision | 08 Sep, 2017 | US9675559 |
|
Email Notification
Critical
| 08 Sep, 2017 | US9675559 |
|
Mail-Petition Decision - Dismissed
Critical
| 07 Sep, 2017 | US9675559 |
| O.P. Petition Decision | 06 Sep, 2017 | US9675559 |
|
Petition Decision - Dismissed
Critical
| 06 Sep, 2017 | US9675559 |
| Petition Entered | 10 Aug, 2017 | US9675559 |
|
Recordation of Patent Grant Mailed
Critical
| 01 Aug, 2017 | US9717740 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 01 Aug, 2017 | US9717740 |
|
Email Notification
Critical
| 21 Jul, 2017 | US9717740 |
|
Application ready for PDX access by participating foreign offices
Critical
| 20 Jul, 2017 | US9717740 |
|
PG-Pub Issue Notification
Critical
| 20 Jul, 2017 | US9717740 |
|
Email Notification
Critical
| 13 Jul, 2017 | US9717740 |
Eton's Family Patents
Eton Drug List
Given below is the complete list of Eton's drugs and the patents protecting them.
1. Alkindi Sprinkle
Alkindi Sprinkle is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9649280 | Composition comprising hydrocortisone |
12 May, 2034
(9 years from now)
| Active |
| US9675559 | Treatment of adrenal insufficiency |
10 Jan, 2033
(8 years from now)
| Active |
| US9717740 | Treatment of adrenal insufficiency |
19 Nov, 2032
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Alkindi Sprinkle's drug page